An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Experimental Drug Acquiring Traction Via Social Media
Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Followers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where communities with thousands of members share comparison photos, injection guides and claims of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Professionals Express Worries
Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.
Several professionals said the popularity for retatrutide could be linked to the increasing cost of approved weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.
Some influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and consumer laws, potentially leading to fines, legal action or prison.
Platform Response and Material Elimination
According to the social media company, the service has taken down problematic content and prohibited associated keywords and search suggestions. The company stated it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Research also discovered groups with up to 9,000 members selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, populated with images of weight loss, glowing reviews and detailed instructions for preparing or administering at residence.
After minutes of joining one community, a seller posted WhatsApp details, where most purchases occur. The seller sent an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.
Item Information and Pricing
Inside these groups, posts show dark colored packages with Royal Mail labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how much time a injector should last, vendors give conflicting answers varying between a several days to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for the messaging service stated it actively moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering substances they can’t verify. Even if the science behind retatrutide is valid, these digital versions may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her staff has previously encountered patients harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly experimental substance not yet approved … may expose patients to possibly significant health risks”.
